Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Preceptor Capital is a venture capital firm founded in 2018 and headquartered in Westlake Village, California. The firm specializes in early-stage investments, focusing on sectors such as healthcare, fintech, and artificial intelligence. With a team of eight professionals, including four partners, Preceptor Capital has built a reputation for providing not only financial support but also practical business advice to its portfolio companies.
The firm has executed over 30 deals since its inception, with a current portfolio of 12 companies. Notable milestones include investments in companies like Oura, which achieved a valuation of $5.2 billion, and Teladoc, a telehealth pioneer that went public on the NYSE. Preceptor Capital's partners leverage their extensive entrepreneurial backgrounds to guide startups through the complexities of early-stage growth.
Preceptor Capital's commitment to mentorship and operational support distinguishes it from traditional venture capital firms. The firm actively engages with its portfolio companies, ensuring that management teams are equipped to navigate challenges and capitalize on opportunities in their respective markets.
Preceptor Capital invests in early-stage businesses across various sectors, including healthcare, fintech, and artificial intelligence. The firm focuses on pre-seed, seed, seed-plus, Series A, Series B, Series C, and growth equity stages. Preceptor Capital emphasizes the importance of value-added capital, which encompasses not only funding but also strategic guidance and mentorship for entrepreneurs.
The firm seeks to partner with management teams that demonstrate strong potential and a clear vision for their businesses. Preceptor Capital's partners, all of whom have entrepreneurial experience, provide hands-on support to help startups navigate challenges and optimize their operations. This mentorship-first approach allows the firm to add significant value beyond financial investment, ensuring that portfolio companies are well-prepared to thrive in competitive markets.
Preceptor Capital's portfolio includes a diverse range of companies, showcasing its commitment to supporting innovative startups. Notable portfolio companies include:
Gary Abrams: Co-Founder, Managing Partner. Gary has extensive experience as an entrepreneur and has led multiple successful ventures in various sectors.
Kevin Blayne: Co-Founder, Managing Partner. Kevin brings a wealth of operational expertise and has a strong background in managing startups.
Henry Dreifus: Co-Founder, Managing Partner. Henry has a proven track record in entrepreneurship and investment, contributing valuable insights to portfolio companies.
Kevin Mencarelli: Co-Founder, Managing Partner. Kevin has significant experience in the startup ecosystem and focuses on providing strategic guidance to founders.
Fabio Viviani: Entrepreneur & Restauranteur. Fabio offers industry-specific insights, particularly in the food and restaurant sectors.
Josh Lippiner: Serial Entrepreneur, Co-Founder & President at PingGPS. Josh brings a wealth of experience in technology startups.
Ray Wilson: Executive in Residence, Boston University Questrom School of Business. Ray provides academic insights and mentorship to portfolio companies.
Clay Medley: President at CEM Automation LLC. Clay offers operational expertise and guidance in automation technologies.
To pitch Preceptor Capital, founders should use the contact form available on the firm's website. A comprehensive pitch deck is essential, including details about the business model, market analysis, and team qualifications. Founders can expect a response within a reasonable timeframe, although specific timelines are not disclosed.
As of 2024, Preceptor Capital has executed over 30 deals, with a current portfolio of 12 companies. Notable exits include Oura, which achieved a valuation of $5.2 billion, and Teladoc, which went public on the NYSE.
The firm continues to focus on mentorship and strategic guidance for its portfolio companies, enhancing their operational capabilities and market positioning.
What are Preceptor Capital's investment criteria?
Preceptor Capital focuses on early-stage investments across healthcare, fintech, and AI sectors. The firm looks for startups that demonstrate strong potential and a clear vision, particularly in pre-seed to Series C stages.
How can I pitch to Preceptor Capital?
Founders can reach out through the contact form on the Preceptor Capital website. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential.
What makes Preceptor Capital different from other investors?
Preceptor Capital distinguishes itself through its mentorship-first approach. The partners have extensive entrepreneurial experience, allowing them to provide practical business advice alongside financial support.
What is the geographic focus of Preceptor Capital?
The firm primarily invests in companies based in the United States, although its portfolio includes international companies, such as Oura from Finland.
What is the typical check size for investments?
While specific check sizes are not disclosed, Preceptor Capital invests across various stages, indicating flexibility in funding amounts based on the needs of the startup.
What kind of post-investment involvement can founders expect?
Founders can expect hands-on mentorship and strategic guidance from the partners at Preceptor Capital, who actively engage with portfolio companies to help them navigate challenges and optimize operations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.